Market Overview

Syneron Settles US Patent Infringement Suit with EndyMed, Eclipse Aesthetics

Related ELOS
Syneron Candela Expands Capabilities of UltraShape Non-Invasive Fat Destruction Platform, Receives FDA Clearance For The New U-Sculpt Transducer And Enhanced Ultrasound Power
ABIOMED Up on License from Opsens - Analyst Blog

Syneron Medical Ltd. (NASDAQ: ELOS), the leading global aesthetic device company announced today, jointly with EndyMed Medical Ltd. and Eclipse Aesthetics, that Syneron has dismissed its United States patent infringement lawsuit against EndyMed and Eclipse Aesthetics relating to EndyMed's Fractional Skin Resurfacing Products. EndyMed and its United States distributor, Eclipse Aesthetics, agreed to immediately stop selling EndyMed's Fractional Skin Resurfacing Products in the United States but may continue to service and support previously purchased products and supply replacement electrodes for them.

Posted-In: News Legal

 

Related Articles (ELOS)

Around the Web, We're Loving...

Get Benzinga's Newsletters